Latest news with #ConestogaCapitalAdvisors
Yahoo
03-05-2025
- Business
- Yahoo
Waste Connections (WCN) Rose Despite Reporting Results Below Street Expectations
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical tensions, and an upcoming announcement on tariffs led to a sharp decline in equities by the end of the first quarter. Investors sought safety, driving U.S. Treasury yields down. The Conestoga Small Cap Composite returned -11.35% (net) in the first quarter compared to the Russell 2000 Growth Index's -11.12% return. The Conestoga SMid Cap Composite returned -5.73% compared to the Russell 2500 Growth Index's -10.80% return. The Conestoga Micro-Cap Composite returned -8.24% vs the Russell Microcap Growth Index's return of -17.75%. Finally, the Conestoga Mid Cap Composite returned 0.96% (net), compared to the Russell Midcap Growth Index's -7.12% return. Please check the top 5 holdings of the fund for a better understanding of their best picks for 2025. In its first-quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as Waste Connections, Inc. (NYSE:WCN). Waste Connections, Inc. (NYSE:WCN) offers non-hazardous waste collection, transfer, disposal, and resource recovery services. The one-month return of Waste Connections, Inc. (NYSE:WCN) was -1.89%, and its shares gained 20.09% of their value over the last 52 weeks. On May 1, 2025, Waste Connections, Inc. (NYSE:WCN) stock closed at $196.18 per share with a market capitalization of $50.692 billion. Conestoga Capital Advisors stated the following regarding Waste Connections, Inc. (NYSE:WCN) in its Q1 2025 investor letter: "Waste Connections, Inc. (NYSE:WCN) is the third largest waste company in North America. Despite its 4Q24 revenue and EBITDA results being below 'Street' expectations, the stock held up well during the quarter. The company's business is fairly recession resistant. In 2025, the company is expected to grow revenues in the mid-single digits, demonstrate solid EBITDA margin improvement and generate significant free cash flow. In a highly volatile equity market, the defensive characteristics of WCN are highly valued by investors." A fleet of waste management trucks driving through a city at sunrise. Waste Connections, Inc. (NYSE:WCN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 49 hedge fund portfolios held Waste Connections, Inc. (NYSE:WCN) at the end of the fourth quarter, compared to 48 in the third quarter. In the first quarter of 2025, Waste Connections, Inc.'s (NYSE:WCN) revenue increased 7.5% year-over-year to $2.228 billion. While we acknowledge the potential of Waste Connections, Inc. (NYSE:WCN) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered Waste Connections, Inc. (NYSE:WCN) and shared Carillon Eagle Mid Cap Growth Fund's views on the company. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
03-05-2025
- Business
- Yahoo
Here's Why Conestoga Capital Advisors Sold Align Technology (ALGN)
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical tensions, and an upcoming announcement on tariffs led to a sharp decline in equities by the end of the first quarter. Investors sought safety, driving U.S. Treasury yields down. The Conestoga Small Cap Composite returned -11.35% (net) in the first quarter compared to the Russell 2000 Growth Index's -11.12% return. The Conestoga SMid Cap Composite returned -5.73% compared to the Russell 2500 Growth Index's -10.80% return. The Conestoga Micro-Cap Composite returned -8.24% vs the Russell Microcap Growth Index's return of -17.75%. Finally, the Conestoga Mid Cap Composite returned 0.96% (net), compared to the Russell Midcap Growth Index's -7.12% return. Please check the top 5 holdings of the fund for a better understanding of their best picks for 2025. In its first-quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as Align Technology, Inc. (NASDAQ:ALGN). Align Technology, Inc. (NASDAQ:ALGN) designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services. The one-month return Align Technology, Inc. (NASDAQ:ALGN) was 14.59%, and its shares lost 38.32% of their value over the last 52 weeks. On May 1, 2025, Align Technology, Inc. (NASDAQ:ALGN) stock closed at $176.74 per share with a market capitalization of $12.939 billion. Conestoga Capital Advisors stated the following regarding Align Technology, Inc. (NASDAQ:ALGN) in its Q1 2025 investor letter: "Align Technology, Inc. (NASDAQ:ALGN) is a global medical-device company that pioneered the invisible-orthodontics market with the introduction of the Invisalign® system, a clear, removable orthodontic-treatment option for straightening teeth. We have exited our position in ALGN given that revenue growth for the business has become more challenged. While ALGN remains the market share leader, it has become increasingly difficult for the company to gain additional share as new competitors have entered the market. Therefore, growth has become more captive to consumer spending cycles. The proceeds have been re-invested in higher conviction Mid Cap holdings." An orthodontist examining a patient's teeth with a intraoral scanner, demonstrating the precision of the company's technology. Align Technology, Inc. (NASDAQ:ALGN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 58 hedge fund portfolios held Align Technology, Inc. (NASDAQ:ALGN) at the end of the fourth quarter, compared to 50 in the third quarter. While we acknowledge the potential of Align Technology, Inc. (NASDAQ:ALGN) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered Align Technology, Inc. (NASDAQ:ALGN) and shared the list of high-risk stocks to buy according to billionaires. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
03-05-2025
- Business
- Yahoo
Here's Why West Pharmaceutical Services (WST) Stock Fell 38%
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical tensions, and an upcoming announcement on tariffs led to a sharp decline in equities by the end of the first quarter. Investors sought safety, driving U.S. Treasury yields down. The Conestoga Small Cap Composite returned -11.35% (net) in the first quarter compared to the Russell 2000 Growth Index's -11.12% return. The Conestoga SMid Cap Composite returned -5.73% compared to the Russell 2500 Growth Index's -10.80% return. The Conestoga Micro-Cap Composite returned -8.24% vs the Russell Microcap Growth Index's return of -17.75%. Finally, the Conestoga Mid Cap Composite returned 0.96% (net), compared to the Russell Midcap Growth Index's -7.12% return. Please check the top 5 holdings of the fund for a better understanding of their best picks for 2025. In its first-quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as West Pharmaceutical Services, Inc. (NYSE:WST). West Pharmaceutical Services, Inc. (NYSE:WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. The one-month return of West Pharmaceutical Services, Inc. (NYSE:WST) was -4.41%, and its shares lost 42.94% of their value over the last 52 weeks. On May 1, 2025, West Pharmaceutical Services, Inc. (NYSE:WST) stock closed at $210.26 per share with a market capitalization of $15.11 billion. Conestoga Capital Advisors stated the following regarding West Pharmaceutical Services, Inc. (NYSE:WST) in its Q1 2025 investor letter: "After being a leader in Q4 on optimism that destocking in the industry was nearly complete, West Pharmaceutical Services, Inc. (NYSE:WST) declined during the quarter. Most of the decline was confined to the day they announced their fourth quarter earnings, which sent shares down 38%, the company's largest single-day move in the company's 40+ years of being publicly traded. Fourth quarter results beat street estimates, but 2025 earnings per share guidance were 22% below expectations. WST announced they're walking away from two large contract manufacturing customers (20% of that segment's revenue), and the ramp of SmartDose is going slower than expected. Additionally, WST is reconsidering its path forward with that product." A closeup of multiple drug containment systems in an array of colors. West Pharmaceutical Services, Inc. (NYSE:WST) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 35 hedge fund portfolios held West Pharmaceutical Services, Inc. (NYSE:WST) at the end of the fourth quarter, compared to 31 in the third quarter. West Pharmaceutical Services, Inc. (NYSE:WST) generated net sales of $698 million in the first quarter, representing an organic sales increase of 2.1%. While we acknowledge the potential of West Pharmaceutical Services, Inc. (NYSE:WST) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered West Pharmaceutical Services, Inc. (NYSE:WST) and shared the list of worst performing stocks in the S&P 500 so far in 2025. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
03-05-2025
- Business
- Yahoo
Here's Why Generac Holdings (GNRC) Fell in Q1
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical tensions, and an upcoming announcement on tariffs led to a sharp decline in equities by the end of the first quarter. Investors sought safety, driving U.S. Treasury yields down. The Conestoga Small Cap Composite returned -11.35% (net) in the first quarter compared to the Russell 2000 Growth Index's -11.12% return. The Conestoga SMid Cap Composite returned -5.73% compared to the Russell 2500 Growth Index's -10.80% return. The Conestoga Micro-Cap Composite returned -8.24% vs the Russell Microcap Growth Index's return of -17.75%. Finally, the Conestoga Mid Cap Composite returned 0.96% (net), compared to the Russell Midcap Growth Index's -7.12% return. Please check the top 5 holdings of the fund for a better understanding of their best picks for 2025. In its first-quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as Generac Holdings Inc. (NYSE:GNRC). Generac Holdings Inc. (NYSE:GNRC) is a power generation equipment, energy storage systems, and other power products manufacturer and supplier. The one-month return of Generac Holdings Inc. (NYSE:GNRC) was -2.57%, and its shares lost 12.43% of their value over the last 52 weeks. On May 1, 2025, Generac Holdings Inc. (NYSE:GNRC) stock closed at $112.67 per share with a market capitalization of $6.68 billion. Conestoga Capital Advisors stated the following regarding Generac Holdings Inc. (NYSE:GNRC) in its Q1 2025 investor letter: "Generac Holdings Inc. (NYSE:GNRC) is a market leader in the design and manufacturing of backup generators for the residential and commercial markets. GNRC delivered solid Q4 results with both revenue and EBITDA above consensus. FY2025 guidance was slightly below street estimates. GNRC does not include any major weather events in its guidance." A technician in protective gear repairing a huge generator at a power plant. Generac Holdings Inc. (NYSE:GNRC) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 59 hedge fund portfolios held Generac Holdings Inc. (NYSE:GNRC) at the end of the fourth quarter, compared to 40 in the third quarter. Generac Holdings Inc.'s (NYSE:GNRC) net sales increased 6% year-over-year to $942 million in the first quarter of 2025. While we acknowledge the potential of Generac Holdings Inc. (NYSE:GNRC) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered Generac Holdings Inc. (NYSE:GNRC) and shared SouthernSun SMID Cap Strategy's views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
03-05-2025
- Business
- Yahoo
Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical tensions, and an upcoming announcement on tariffs led to a sharp decline in equities by the end of the first quarter. Investors sought safety, driving U.S. Treasury yields down. The Conestoga Small Cap Composite returned -11.35% (net) in the first quarter compared to the Russell 2000 Growth Index's -11.12% return. The Conestoga SMid Cap Composite returned -5.73% compared to the Russell 2500 Growth Index's -10.80% return. The Conestoga Micro-Cap Composite returned -8.24% vs the Russell Microcap Growth Index's return of -17.75%. Finally, the Conestoga Mid Cap Composite returned 0.96% (net), compared to the Russell Midcap Growth Index's -7.12% return. Please check the top 5 holdings of the fund for a better understanding of their best picks for 2025. In its first-quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as Repligen Corporation (NASDAQ:RGEN). Repligen Corporation (NASDAQ:RGEN) develops and distributes bioprocessing technologies and systems. The one-month return of Repligen Corporation (NASDAQ:RGEN) was 22.57%, and its shares lost 17.87% of their value over the last 52 weeks. On May 1, 2025, Repligen Corporation (NASDAQ:RGEN) stock closed at $137.20 per share with a market capitalization of $7.708 billion. Conestoga Capital Advisors stated the following regarding Repligen Corporation (NASDAQ:RGEN) in its Q1 2025 investor letter: "Repligen Corporation (NASDAQ:RGEN) is a provider of tools used by biotechnology companies. RGEN reported in-line Q4 2024 results and 2025 guidance. The stock rose on the earnings release but fell later in the quarter on rising uncertainty related to U.S. Federal Government spending on healthcare initiatives. Companies with exposure to the bio-processing industry remained under pressure during the first quarter of 2025. We maintain our high conviction in RGEN as we believe there are indications of improving fundamentals for the business." A technician in a lab inspecting an ELISA test kit for use in biopharmaceutical diagnostics. Repligen Corporation (NASDAQ:RGEN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 34 hedge fund portfolios held Repligen Corporation (NASDAQ:RGEN) at the end of the fourth quarter, compared to 34 in the third quarter. While we acknowledge the potential of Repligen Corporation (NASDAQ:RGEN) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered Repligen Corporation (NASDAQ:RGEN) and shared the list of the best-performing stocks from the last 20 years, as listed by Jim Cramer. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
